---
title: "JOHNSON OWEN E — Ownership Dossier"
canonical: https://whiteintel.dev/entity/09d5ef2b-aae0-5a97-b37b-075ce8ffac2f
json: https://whiteintel.dev/api/public/dossier/09d5ef2b-aae0-5a97-b37b-075ce8ffac2f
identifier: sec:0001408298
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# JOHNSON OWEN E

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001408298`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/09d5ef2b-aae0-5a97-b37b-075ce8ffac2f  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/09d5ef2b-aae0-5a97-b37b-075ce8ffac2f  

## Ownership & control

### Holdings / subsidiaries

- **NAVIDEA BIOPHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/df8b44cc-c335-50e4-ba43-37be3a1ac1a0

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **JOHNSON OWEN E**. Human view: https://whiteintel.dev/entity/09d5ef2b-aae0-5a97-b37b-075ce8ffac2f · Structured JSON: https://whiteintel.dev/api/public/dossier/09d5ef2b-aae0-5a97-b37b-075ce8ffac2f._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._